{"Abstract": "The 2017 Endocrine Society treatment guidelines for adult transgender individuals have significantly impacted the field of transgender medicine. This update reviews recent advancements in gender-affirming hormone treatment, including the use of testosterone and estrogen for transmasculine and transfeminine individuals, respectively. The guidelines emphasize the importance of individualized treatment plans, careful consideration of comorbidities, and long-term follow-up. Emerging evidence suggests that hormone therapy can improve mental health outcomes, reduce symptoms of dysphoria, and enhance quality of life for transgender adults. This review highlights key updates to the 2017 guidelines and discusses the implications for clinical practice and future research in transgender medicine."}